SlideShare una empresa de Scribd logo
1 de 42
kasr al ainy school of Medicine Cairo University   CHANGING ATTITUDES IN OVARIAN STIMULATION
CHANGING ATTITUDE IS A FACT OF LIFE ,[object Object],[object Object]
THE BEST MODEL  ,[object Object]
WHAT ABOUT GYNECOLOGY ,[object Object]
IVF ,[object Object]
16 follicles 12 mature oocytes 14 oocytes Extras frozen if good 2 to 3 transferred 9 fertilize normally 5 divide normally 30-40% of couples 4 stop dividing & sperm Typical progression
OHSS is the most serious complication  of ovulation induction.
PROTOCOLS FOR IVF  GnRH Antagonist Protocols GnRH  Agonist Protocols   225 IU per day (150 IU Europe ) Individualized Dosing of FSH/HMG 250 mg per day antagonist Individualized Dosing of FSH/HMG GnRHa 1.0 mg per day  up to 21 days 0.5 mg per day of GnRHa 225 IU per day (150 IU Europe ) Day 6 of  FSH/HMG Day of  hCG Day 1  of FSH/HMG Day 6 of  FSH/HMG Day of hCG 7 – 8 days after estimated ovulation Down regulation Day 2 or 3 of menses Day 1  FSH/HMG
SHOULD BE EVIDENCE BASED ,[object Object],[object Object]
AL-INANY & ABOULGHAR, 2001
AL-INANY ET AL., 2006  ,[object Object]
AL-INANY  ET AL., 2010 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
IT IS JUSTIFIED TO ,[object Object]
WHY:  (AL-INANY ET AL, 2010)
HOW TO EXPLAIN ,[object Object],[object Object],[object Object],[object Object],[object Object]
NUMBER NEEDED TO HARM ,[object Object],[object Object]
CANCELLATION FOR RISK OF OHSS
CONSIDERING CYCLES CANCELLED FOR RISK OF OHSS ,[object Object],[object Object]
[object Object]
LIVE BIRTH RATE
CPR
MISCARRIAGE RATE
IN FAVOR OF ANTAGONIST ,[object Object],[object Object],[object Object]
3. 0  ampoules less with GnRH antagonists p<0.0 7   FSH requirement
1. 1  less days with antagonists p<0.001 Duration of FSH treatment
HOW TO EXPLAIN IMPROVED EFFICACY ,[object Object]
LH STABILITY: AGONIST VS. ANATGONIST
FIXED DOSE PROTOCOL
Flexible antagonist stimulation
Meta-analysis of clinical pregnancy rate in fixed and flexible protocols for GnRH antagonist protocols Al-Inany et al. 2005
FURTHER ANALYSIS ,[object Object],[object Object],[object Object],[object Object]
SO OUR CONCLUSION:  ,[object Object]
BUT NOT ALL DOCTORS WOULD GO FOR ANTAGONIST
(GNRH) ANTAGONISTS: OFF LABEL INDICATION  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
VALUE ,[object Object]
 
OUR RESULTS Parameter Coasting (n = 96) Antagonist (n = 94) P-value Age (years) 30.0 ± 4.9 29.6 ± 4.6 NS Duration of infertility (years) 6.64 ± 4.45 7.07 ± 4.3 NS No. of HMG injections 30.52 ± 8.9 29.94 ± 8.8 NS Days of stimulation 1 9.1 ± 1.5 9.4 ± 1.5 NS Peak oestradiol (pg/ml) 5087 ± 1589 5305 ± 1680 NS Oestradiol on day of HCG (pg/ml) 2605 ± 790 2721 ± 699 NS Range of oestradiol on day of HCG (pg/ml)  1110–4136 1223–4093 NS Day of intervention 2.82 ± 0.97 1.74 ± 0.91 <0.0001 No. of oocytes 14.06 ± 5.20 16.5 ± 7.60 0.02 No. of MII oocytes  11.13 ± 4.60 13.14 ± 6.60 NS No. of fertilized oocytes    7.97 ± 3.80    9.14 ± 4.70 NS No. of high quality embryos    2.21 ± 1.10    2.87 ± 1.20 0.0001 No. of embryos transferred    2.83 ± 0.50    2.79 ± 0.40 NS No. of cryopreserved embryos    4.50 ± 3.93    5.77 ± 4.87 NS Clinical pregnancy (%) 46/96  (47.9) 52/94  (55.3) NS Multiple pregnancy (%) 15/46 (32.6) 17/52 (32.7) NS
THE FUTURE  ,[object Object],[object Object]
JUST A QUESTION ,[object Object]
SIMPLE, SHORTER  SAFER
WHY CHANGING ATTITUDE  ,[object Object],[object Object]
THANK YOU Dr. Hesham Al-Inany  MD, PhD e-mail : hesham@khosoba.com

Más contenido relacionado

La actualidad más candente

OVARIAN RESERVE DIAGNOSIS & MANAGEMENT DR Sharda Jain
OVARIAN RESERVE DIAGNOSIS & MANAGEMENT DR Sharda Jain OVARIAN RESERVE DIAGNOSIS & MANAGEMENT DR Sharda Jain
OVARIAN RESERVE DIAGNOSIS & MANAGEMENT DR Sharda Jain Lifecare Centre
 
Management of thin endometrium isar 2019
Management of thin endometrium isar 2019Management of thin endometrium isar 2019
Management of thin endometrium isar 2019Poonam Loomba
 
MANAGEMENT OF POOR RESPONDERS IN IVF BY DR SHASHWAT JANI
MANAGEMENT OF POOR RESPONDERS  IN IVF BY DR SHASHWAT JANIMANAGEMENT OF POOR RESPONDERS  IN IVF BY DR SHASHWAT JANI
MANAGEMENT OF POOR RESPONDERS IN IVF BY DR SHASHWAT JANIDR SHASHWAT JANI
 
Diagnosis and Management of Poor Ovarian Reserve : Evidence & Practice
Diagnosis and Management of Poor Ovarian Reserve : Evidence & Practice Diagnosis and Management of Poor Ovarian Reserve : Evidence & Practice
Diagnosis and Management of Poor Ovarian Reserve : Evidence & Practice Sujoy Dasgupta
 
Tens Secrets to Ovarian Stimulation
Tens Secrets to Ovarian StimulationTens Secrets to Ovarian Stimulation
Tens Secrets to Ovarian Stimulationjaideepmalhotra1960
 
Luteal phase support in ivf
Luteal phase support in ivfLuteal phase support in ivf
Luteal phase support in ivfmagdy abdel
 
Adjuvants in por (1)
Adjuvants in por (1)Adjuvants in por (1)
Adjuvants in por (1)rupalibassi
 
Treatment of poor responders: Review of Systematic reviews 2016
Treatment of poor responders: Review of Systematic reviews 2016 Treatment of poor responders: Review of Systematic reviews 2016
Treatment of poor responders: Review of Systematic reviews 2016 Aboubakr Elnashar
 
Management of poor ovarian response
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian responseHesham Gaber
 
Ovulation Stimulation Protocols for IUI - Dr Dhorepatil Bharati
Ovulation Stimulation Protocols for IUI - Dr Dhorepatil BharatiOvulation Stimulation Protocols for IUI - Dr Dhorepatil Bharati
Ovulation Stimulation Protocols for IUI - Dr Dhorepatil BharatiBharati Dhorepatil
 
Thin Endometrium & Infertility
Thin Endometrium & InfertilityThin Endometrium & Infertility
Thin Endometrium & InfertilityLifecare Centre
 
Panel IUI by DR SHASHWAT JANI ( Optimizing Success in Intrauterine Inseminati...
Panel IUI by DR SHASHWAT JANI ( Optimizing Success in Intrauterine Inseminati...Panel IUI by DR SHASHWAT JANI ( Optimizing Success in Intrauterine Inseminati...
Panel IUI by DR SHASHWAT JANI ( Optimizing Success in Intrauterine Inseminati...DR SHASHWAT JANI
 
POOR RESPONDERS: Minimal Vs. Maximal stimulation
POOR RESPONDERS: Minimal Vs. Maximal stimulationPOOR RESPONDERS: Minimal Vs. Maximal stimulation
POOR RESPONDERS: Minimal Vs. Maximal stimulationAboubakr Elnashar
 
How to stimulate your patient for IVF / ICSI
How to stimulate your patient for IVF / ICSIHow to stimulate your patient for IVF / ICSI
How to stimulate your patient for IVF / ICSIHesham Al-Inany
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationAboubakr Elnashar
 
Gonadotrpin ovarian stimulation: Aboubakr elnashar
Gonadotrpin ovarian stimulation: Aboubakr elnasharGonadotrpin ovarian stimulation: Aboubakr elnashar
Gonadotrpin ovarian stimulation: Aboubakr elnasharAboubakr Elnashar
 

La actualidad más candente (20)

AN IDEAL OVULATION INDUCTION REGIMEN
AN IDEAL OVULATION INDUCTION REGIMENAN IDEAL OVULATION INDUCTION REGIMEN
AN IDEAL OVULATION INDUCTION REGIMEN
 
OVARIAN RESERVE DIAGNOSIS & MANAGEMENT DR Sharda Jain
OVARIAN RESERVE DIAGNOSIS & MANAGEMENT DR Sharda Jain OVARIAN RESERVE DIAGNOSIS & MANAGEMENT DR Sharda Jain
OVARIAN RESERVE DIAGNOSIS & MANAGEMENT DR Sharda Jain
 
Management of thin endometrium isar 2019
Management of thin endometrium isar 2019Management of thin endometrium isar 2019
Management of thin endometrium isar 2019
 
MANAGEMENT OF POOR RESPONDERS IN IVF BY DR SHASHWAT JANI
MANAGEMENT OF POOR RESPONDERS  IN IVF BY DR SHASHWAT JANIMANAGEMENT OF POOR RESPONDERS  IN IVF BY DR SHASHWAT JANI
MANAGEMENT OF POOR RESPONDERS IN IVF BY DR SHASHWAT JANI
 
Diagnosis and Management of Poor Ovarian Reserve : Evidence & Practice
Diagnosis and Management of Poor Ovarian Reserve : Evidence & Practice Diagnosis and Management of Poor Ovarian Reserve : Evidence & Practice
Diagnosis and Management of Poor Ovarian Reserve : Evidence & Practice
 
Tens Secrets to Ovarian Stimulation
Tens Secrets to Ovarian StimulationTens Secrets to Ovarian Stimulation
Tens Secrets to Ovarian Stimulation
 
Luteal phase support in ivf
Luteal phase support in ivfLuteal phase support in ivf
Luteal phase support in ivf
 
Adjuvants in por (1)
Adjuvants in por (1)Adjuvants in por (1)
Adjuvants in por (1)
 
Treatment of poor responders: Review of Systematic reviews 2016
Treatment of poor responders: Review of Systematic reviews 2016 Treatment of poor responders: Review of Systematic reviews 2016
Treatment of poor responders: Review of Systematic reviews 2016
 
Luteal phase support in ART
Luteal phase support in ARTLuteal phase support in ART
Luteal phase support in ART
 
Management of poor ovarian response
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian response
 
Ovulation Stimulation Protocols for IUI - Dr Dhorepatil Bharati
Ovulation Stimulation Protocols for IUI - Dr Dhorepatil BharatiOvulation Stimulation Protocols for IUI - Dr Dhorepatil Bharati
Ovulation Stimulation Protocols for IUI - Dr Dhorepatil Bharati
 
Thin Endometrium & Infertility
Thin Endometrium & InfertilityThin Endometrium & Infertility
Thin Endometrium & Infertility
 
Panel IUI by DR SHASHWAT JANI ( Optimizing Success in Intrauterine Inseminati...
Panel IUI by DR SHASHWAT JANI ( Optimizing Success in Intrauterine Inseminati...Panel IUI by DR SHASHWAT JANI ( Optimizing Success in Intrauterine Inseminati...
Panel IUI by DR SHASHWAT JANI ( Optimizing Success in Intrauterine Inseminati...
 
POOR RESPONDERS: Minimal Vs. Maximal stimulation
POOR RESPONDERS: Minimal Vs. Maximal stimulationPOOR RESPONDERS: Minimal Vs. Maximal stimulation
POOR RESPONDERS: Minimal Vs. Maximal stimulation
 
How to stimulate your patient for IVF / ICSI
How to stimulate your patient for IVF / ICSIHow to stimulate your patient for IVF / ICSI
How to stimulate your patient for IVF / ICSI
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulation
 
OVARIAN RESERVE
OVARIAN RESERVEOVARIAN RESERVE
OVARIAN RESERVE
 
Gonadotrpin ovarian stimulation: Aboubakr elnashar
Gonadotrpin ovarian stimulation: Aboubakr elnasharGonadotrpin ovarian stimulation: Aboubakr elnashar
Gonadotrpin ovarian stimulation: Aboubakr elnashar
 
Optimizing IUI Outcome
Optimizing IUI OutcomeOptimizing IUI Outcome
Optimizing IUI Outcome
 

Destacado

GnRH Agonists & Antagonists
GnRH Agonists & AntagonistsGnRH Agonists & Antagonists
GnRH Agonists & AntagonistsManas Nath
 
Ovarian Stimulation Protocols
Ovarian Stimulation ProtocolsOvarian Stimulation Protocols
Ovarian Stimulation ProtocolsHesham Gaber
 
GnRH agonist versus antagonist and impact on cycle outcome
GnRH agonist versus antagonist and impact on cycle outcomeGnRH agonist versus antagonist and impact on cycle outcome
GnRH agonist versus antagonist and impact on cycle outcomeSandro Esteves
 
Management of poor ovarian response
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian responseHesham Gaber
 
GnRH Agonist vs GnRH Antagonist what to choose?
GnRH Agonist vs GnRH Antagonist what to choose?GnRH Agonist vs GnRH Antagonist what to choose?
GnRH Agonist vs GnRH Antagonist what to choose?DrRitu Santwani
 
Gonadotropin Releasing Hormone (GnRH)
Gonadotropin Releasing Hormone (GnRH)Gonadotropin Releasing Hormone (GnRH)
Gonadotropin Releasing Hormone (GnRH)Nazmul Ahmed Oli
 
Optimizing Treatment Outcome in ART
Optimizing Treatment Outcome in ARTOptimizing Treatment Outcome in ART
Optimizing Treatment Outcome in ARTSandro Esteves
 
Antagonist or agonist
Antagonist or agonistAntagonist or agonist
Antagonist or agonistSantosh Gupta
 
Agonists and antagonists in controlled ovarian stimulation
Agonists and antagonists in controlled ovarian stimulationAgonists and antagonists in controlled ovarian stimulation
Agonists and antagonists in controlled ovarian stimulationSandro Esteves
 
LH in Human Reproduction
LH in Human ReproductionLH in Human Reproduction
LH in Human ReproductionSandro Esteves
 
Managing Difficult Infertile Patients
Managing Difficult Infertile PatientsManaging Difficult Infertile Patients
Managing Difficult Infertile PatientsDr Aniruddha Malpani
 
Individualization
IndividualizationIndividualization
Individualizationt7260678
 
C.1 menstrual cycle
C.1   menstrual cycleC.1   menstrual cycle
C.1 menstrual cycleserenaasya
 
Physiology of labor. Anaesthesia in labor
Physiology of labor. Anaesthesia in laborPhysiology of labor. Anaesthesia in labor
Physiology of labor. Anaesthesia in laborberbets
 
R lh supplementation to rfsh in gnrh antagonist cycles
R lh supplementation to rfsh in gnrh antagonist cyclesR lh supplementation to rfsh in gnrh antagonist cycles
R lh supplementation to rfsh in gnrh antagonist cyclesAlfredo Nazzaro
 
Vitrification in IVF
Vitrification in IVFVitrification in IVF
Vitrification in IVFG A RAMA Raju
 
Abortion & ectopic pregnancy by liza tarca, md
Abortion & ectopic pregnancy by liza tarca, mdAbortion & ectopic pregnancy by liza tarca, md
Abortion & ectopic pregnancy by liza tarca, mdLiza Tarca
 
Tema 27 _anticancerosos_bis
Tema 27 _anticancerosos_bisTema 27 _anticancerosos_bis
Tema 27 _anticancerosos_bisslayerail
 
IVF – ICSI in PCOS DIFFICULTIES AND SOLUTIONS Dr. Sharda Jain Dr. Jyoti Bha...
 IVF – ICSI in PCOS DIFFICULTIES AND SOLUTIONS Dr. Sharda Jain  Dr. Jyoti Bha... IVF – ICSI in PCOS DIFFICULTIES AND SOLUTIONS Dr. Sharda Jain  Dr. Jyoti Bha...
IVF – ICSI in PCOS DIFFICULTIES AND SOLUTIONS Dr. Sharda Jain Dr. Jyoti Bha...Lifecare Centre
 

Destacado (20)

GnRH Agonists & Antagonists
GnRH Agonists & AntagonistsGnRH Agonists & Antagonists
GnRH Agonists & Antagonists
 
Ovarian Stimulation Protocols
Ovarian Stimulation ProtocolsOvarian Stimulation Protocols
Ovarian Stimulation Protocols
 
GnRH agonist versus antagonist and impact on cycle outcome
GnRH agonist versus antagonist and impact on cycle outcomeGnRH agonist versus antagonist and impact on cycle outcome
GnRH agonist versus antagonist and impact on cycle outcome
 
Management of poor ovarian response
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian response
 
GnRH Agonist vs GnRH Antagonist what to choose?
GnRH Agonist vs GnRH Antagonist what to choose?GnRH Agonist vs GnRH Antagonist what to choose?
GnRH Agonist vs GnRH Antagonist what to choose?
 
Gonadotropin Releasing Hormone (GnRH)
Gonadotropin Releasing Hormone (GnRH)Gonadotropin Releasing Hormone (GnRH)
Gonadotropin Releasing Hormone (GnRH)
 
Optimizing Treatment Outcome in ART
Optimizing Treatment Outcome in ARTOptimizing Treatment Outcome in ART
Optimizing Treatment Outcome in ART
 
Antagonist or agonist
Antagonist or agonistAntagonist or agonist
Antagonist or agonist
 
Agonists and antagonists in controlled ovarian stimulation
Agonists and antagonists in controlled ovarian stimulationAgonists and antagonists in controlled ovarian stimulation
Agonists and antagonists in controlled ovarian stimulation
 
LH in Human Reproduction
LH in Human ReproductionLH in Human Reproduction
LH in Human Reproduction
 
Managing Difficult Infertile Patients
Managing Difficult Infertile PatientsManaging Difficult Infertile Patients
Managing Difficult Infertile Patients
 
Individualization
IndividualizationIndividualization
Individualization
 
Enzymes
EnzymesEnzymes
Enzymes
 
C.1 menstrual cycle
C.1   menstrual cycleC.1   menstrual cycle
C.1 menstrual cycle
 
Physiology of labor. Anaesthesia in labor
Physiology of labor. Anaesthesia in laborPhysiology of labor. Anaesthesia in labor
Physiology of labor. Anaesthesia in labor
 
R lh supplementation to rfsh in gnrh antagonist cycles
R lh supplementation to rfsh in gnrh antagonist cyclesR lh supplementation to rfsh in gnrh antagonist cycles
R lh supplementation to rfsh in gnrh antagonist cycles
 
Vitrification in IVF
Vitrification in IVFVitrification in IVF
Vitrification in IVF
 
Abortion & ectopic pregnancy by liza tarca, md
Abortion & ectopic pregnancy by liza tarca, mdAbortion & ectopic pregnancy by liza tarca, md
Abortion & ectopic pregnancy by liza tarca, md
 
Tema 27 _anticancerosos_bis
Tema 27 _anticancerosos_bisTema 27 _anticancerosos_bis
Tema 27 _anticancerosos_bis
 
IVF – ICSI in PCOS DIFFICULTIES AND SOLUTIONS Dr. Sharda Jain Dr. Jyoti Bha...
 IVF – ICSI in PCOS DIFFICULTIES AND SOLUTIONS Dr. Sharda Jain  Dr. Jyoti Bha... IVF – ICSI in PCOS DIFFICULTIES AND SOLUTIONS Dr. Sharda Jain  Dr. Jyoti Bha...
IVF – ICSI in PCOS DIFFICULTIES AND SOLUTIONS Dr. Sharda Jain Dr. Jyoti Bha...
 

Similar a GnRH antagonists

GnRH antagonist in Ovarian stimulation for IVF/ET, Prof. Usama M.Fouda
GnRH antagonist in Ovarian stimulation for   IVF/ET, Prof. Usama M.Fouda GnRH antagonist in Ovarian stimulation for   IVF/ET, Prof. Usama M.Fouda
GnRH antagonist in Ovarian stimulation for IVF/ET, Prof. Usama M.Fouda umfrfouda
 
PCOS - Ovulation Induction 2 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 2 - Dr Bharati DhorepatilPCOS - Ovulation Induction 2 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 2 - Dr Bharati DhorepatilBharati Dhorepatil
 
ovarian stimulation : a 2018 update
ovarian stimulation : a 2018 updateovarian stimulation : a 2018 update
ovarian stimulation : a 2018 updateHesham Al-Inany
 
Medical managment of ovarian hyperstimulation
Medical managment of ovarian hyperstimulationMedical managment of ovarian hyperstimulation
Medical managment of ovarian hyperstimulationLifecare Centre
 
OVARIAN HYPERSTIMULATION SYNDROME (OHSS) : Our Experience in 580 IVF Cycles,...
OVARIAN HYPERSTIMULATION SYNDROME (OHSS)  : Our Experience in 580 IVF Cycles,...OVARIAN HYPERSTIMULATION SYNDROME (OHSS)  : Our Experience in 580 IVF Cycles,...
OVARIAN HYPERSTIMULATION SYNDROME (OHSS) : Our Experience in 580 IVF Cycles,...DelhiGynaecologistForum
 
New developments in reproductive medicine (1)
New developments in reproductive medicine (1)New developments in reproductive medicine (1)
New developments in reproductive medicine (1)鋒博 蔡
 
New developments in reproductive medicine
New developments in reproductive medicineNew developments in reproductive medicine
New developments in reproductive medicine鋒博 蔡
 
複製 New developments in reproductive medicine
複製  New developments in reproductive medicine複製  New developments in reproductive medicine
複製 New developments in reproductive medicinet7260678
 
New developments in reproductive medicine (1)
New developments in reproductive medicine (1)New developments in reproductive medicine (1)
New developments in reproductive medicine (1)t7260678
 
New developments in reproductive medicine
New developments in reproductive medicineNew developments in reproductive medicine
New developments in reproductive medicinet7260678
 
New developments in reproductive medicine (1)
New developments in reproductive medicine (1)New developments in reproductive medicine (1)
New developments in reproductive medicine (1)鋒博 蔡
 
New developments in reproductive medicine
New developments in reproductive medicineNew developments in reproductive medicine
New developments in reproductive medicine鋒博 蔡
 
To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...
To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...
To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...Candido Tomás
 

Similar a GnRH antagonists (20)

GnRH Agonist Versus GnRH Antagonist
GnRH Agonist Versus GnRH AntagonistGnRH Agonist Versus GnRH Antagonist
GnRH Agonist Versus GnRH Antagonist
 
High responders
High respondersHigh responders
High responders
 
Ovarian hyper stimulation syndrome ohss
Ovarian hyper stimulation syndrome ohssOvarian hyper stimulation syndrome ohss
Ovarian hyper stimulation syndrome ohss
 
GnRH antagonist in Ovarian stimulation for IVF/ET, Prof. Usama M.Fouda
GnRH antagonist in Ovarian stimulation for   IVF/ET, Prof. Usama M.Fouda GnRH antagonist in Ovarian stimulation for   IVF/ET, Prof. Usama M.Fouda
GnRH antagonist in Ovarian stimulation for IVF/ET, Prof. Usama M.Fouda
 
PCOS - Ovulation Induction 2 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 2 - Dr Bharati DhorepatilPCOS - Ovulation Induction 2 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 2 - Dr Bharati Dhorepatil
 
ovarian stimulation : a 2018 update
ovarian stimulation : a 2018 updateovarian stimulation : a 2018 update
ovarian stimulation : a 2018 update
 
Subfertility
SubfertilitySubfertility
Subfertility
 
Ovarian drilling
Ovarian drillingOvarian drilling
Ovarian drilling
 
Medical managment of ovarian hyperstimulation
Medical managment of ovarian hyperstimulationMedical managment of ovarian hyperstimulation
Medical managment of ovarian hyperstimulation
 
OVARIAN HYPERSTIMULATION SYNDROME (OHSS) : Our Experience in 580 IVF Cycles,...
OVARIAN HYPERSTIMULATION SYNDROME (OHSS)  : Our Experience in 580 IVF Cycles,...OVARIAN HYPERSTIMULATION SYNDROME (OHSS)  : Our Experience in 580 IVF Cycles,...
OVARIAN HYPERSTIMULATION SYNDROME (OHSS) : Our Experience in 580 IVF Cycles,...
 
Ohss
OhssOhss
Ohss
 
New developments in reproductive medicine (1)
New developments in reproductive medicine (1)New developments in reproductive medicine (1)
New developments in reproductive medicine (1)
 
New developments in reproductive medicine
New developments in reproductive medicineNew developments in reproductive medicine
New developments in reproductive medicine
 
複製 New developments in reproductive medicine
複製  New developments in reproductive medicine複製  New developments in reproductive medicine
複製 New developments in reproductive medicine
 
New developments in reproductive medicine (1)
New developments in reproductive medicine (1)New developments in reproductive medicine (1)
New developments in reproductive medicine (1)
 
New developments in reproductive medicine
New developments in reproductive medicineNew developments in reproductive medicine
New developments in reproductive medicine
 
New developments in reproductive medicine (1)
New developments in reproductive medicine (1)New developments in reproductive medicine (1)
New developments in reproductive medicine (1)
 
New developments in reproductive medicine
New developments in reproductive medicineNew developments in reproductive medicine
New developments in reproductive medicine
 
To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...
To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...
To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...
 
Ivf in pcos
Ivf in pcosIvf in pcos
Ivf in pcos
 

Más de Hesham Gaber

So much evidence 1
So much evidence 1So much evidence 1
So much evidence 1Hesham Gaber
 
So much evidence 1
So much evidence 1So much evidence 1
So much evidence 1Hesham Gaber
 
Thromboprophylaxis
ThromboprophylaxisThromboprophylaxis
ThromboprophylaxisHesham Gaber
 
Pattern of vitamin d receptor polymorphism
Pattern of vitamin d receptor polymorphism Pattern of vitamin d receptor polymorphism
Pattern of vitamin d receptor polymorphism Hesham Gaber
 
Why to know statistics
Why to know statisticsWhy to know statistics
Why to know statisticsHesham Gaber
 
Statistics & infertility
Statistics & infertilityStatistics & infertility
Statistics & infertilityHesham Gaber
 
Research methodology 101
Research methodology 101Research methodology 101
Research methodology 101Hesham Gaber
 
Randomised controlled trials
Randomised controlled trialsRandomised controlled trials
Randomised controlled trialsHesham Gaber
 
Ovarian hyperstimulation syndrome
Ovarian hyperstimulation syndromeOvarian hyperstimulation syndrome
Ovarian hyperstimulation syndromeHesham Gaber
 
Management of ovarian cysts in postmenopausal women
Management of ovarian cysts in postmenopausal womenManagement of ovarian cysts in postmenopausal women
Management of ovarian cysts in postmenopausal womenHesham Gaber
 

Más de Hesham Gaber (20)

Prognostic models
Prognostic modelsPrognostic models
Prognostic models
 
Poor
PoorPoor
Poor
 
Infertility
InfertilityInfertility
Infertility
 
So much evidence 1
So much evidence 1So much evidence 1
So much evidence 1
 
So much evidence 1
So much evidence 1So much evidence 1
So much evidence 1
 
Contraception
ContraceptionContraception
Contraception
 
Thromboprophylaxis
ThromboprophylaxisThromboprophylaxis
Thromboprophylaxis
 
Pattern of vitamin d receptor polymorphism
Pattern of vitamin d receptor polymorphism Pattern of vitamin d receptor polymorphism
Pattern of vitamin d receptor polymorphism
 
So much evidence
So much evidenceSo much evidence
So much evidence
 
Why to know statistics
Why to know statisticsWhy to know statistics
Why to know statistics
 
Uterine sarcoma
Uterine sarcomaUterine sarcoma
Uterine sarcoma
 
Systematic review
Systematic reviewSystematic review
Systematic review
 
Statistics & infertility
Statistics & infertilityStatistics & infertility
Statistics & infertility
 
Research methodology 101
Research methodology 101Research methodology 101
Research methodology 101
 
Randomised controlled trials
Randomised controlled trialsRandomised controlled trials
Randomised controlled trials
 
Paternal age
Paternal agePaternal age
Paternal age
 
Ovarian hyperstimulation syndrome
Ovarian hyperstimulation syndromeOvarian hyperstimulation syndrome
Ovarian hyperstimulation syndrome
 
Management of ovarian cysts in postmenopausal women
Management of ovarian cysts in postmenopausal womenManagement of ovarian cysts in postmenopausal women
Management of ovarian cysts in postmenopausal women
 
Male infertility
Male infertilityMale infertility
Male infertility
 
Intersexuality
IntersexualityIntersexuality
Intersexuality
 

Último

Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Celine George
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
Karra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxKarra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxAshokKarra1
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...Postal Advocate Inc.
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for BeginnersSabitha Banu
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Mark Reed
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️9953056974 Low Rate Call Girls In Saket, Delhi NCR
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...Nguyen Thanh Tu Collection
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4MiaBumagat1
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPCeline George
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)lakshayb543
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptxSherlyMaeNeri
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptxmary850239
 
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxGrade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxChelloAnnAsuncion2
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 

Último (20)

Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17
 
Raw materials used in Herbal Cosmetics.pptx
Raw materials used in Herbal Cosmetics.pptxRaw materials used in Herbal Cosmetics.pptx
Raw materials used in Herbal Cosmetics.pptx
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
Karra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxKarra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptx
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for Beginners
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERP
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptx
 
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptxYOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
 
OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx
 
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxGrade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
 
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptxYOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 

GnRH antagonists

  • 1. kasr al ainy school of Medicine Cairo University CHANGING ATTITUDES IN OVARIAN STIMULATION
  • 2.
  • 3.
  • 4.
  • 5.
  • 6. 16 follicles 12 mature oocytes 14 oocytes Extras frozen if good 2 to 3 transferred 9 fertilize normally 5 divide normally 30-40% of couples 4 stop dividing & sperm Typical progression
  • 7. OHSS is the most serious complication of ovulation induction.
  • 8. PROTOCOLS FOR IVF GnRH Antagonist Protocols GnRH Agonist Protocols 225 IU per day (150 IU Europe ) Individualized Dosing of FSH/HMG 250 mg per day antagonist Individualized Dosing of FSH/HMG GnRHa 1.0 mg per day up to 21 days 0.5 mg per day of GnRHa 225 IU per day (150 IU Europe ) Day 6 of FSH/HMG Day of hCG Day 1 of FSH/HMG Day 6 of FSH/HMG Day of hCG 7 – 8 days after estimated ovulation Down regulation Day 2 or 3 of menses Day 1 FSH/HMG
  • 9.
  • 11.
  • 12.
  • 13.
  • 14. WHY: (AL-INANY ET AL, 2010)
  • 15.
  • 16.
  • 18.
  • 19.
  • 21. CPR
  • 23.
  • 24. 3. 0 ampoules less with GnRH antagonists p<0.0 7 FSH requirement
  • 25. 1. 1 less days with antagonists p<0.001 Duration of FSH treatment
  • 26.
  • 27. LH STABILITY: AGONIST VS. ANATGONIST
  • 30. Meta-analysis of clinical pregnancy rate in fixed and flexible protocols for GnRH antagonist protocols Al-Inany et al. 2005
  • 31.
  • 32.
  • 33. BUT NOT ALL DOCTORS WOULD GO FOR ANTAGONIST
  • 34.
  • 35.
  • 36.  
  • 37. OUR RESULTS Parameter Coasting (n = 96) Antagonist (n = 94) P-value Age (years) 30.0 ± 4.9 29.6 ± 4.6 NS Duration of infertility (years) 6.64 ± 4.45 7.07 ± 4.3 NS No. of HMG injections 30.52 ± 8.9 29.94 ± 8.8 NS Days of stimulation 1 9.1 ± 1.5 9.4 ± 1.5 NS Peak oestradiol (pg/ml) 5087 ± 1589 5305 ± 1680 NS Oestradiol on day of HCG (pg/ml) 2605 ± 790 2721 ± 699 NS Range of oestradiol on day of HCG (pg/ml) 1110–4136 1223–4093 NS Day of intervention 2.82 ± 0.97 1.74 ± 0.91 <0.0001 No. of oocytes 14.06 ± 5.20 16.5 ± 7.60 0.02 No. of MII oocytes 11.13 ± 4.60 13.14 ± 6.60 NS No. of fertilized oocytes   7.97 ± 3.80   9.14 ± 4.70 NS No. of high quality embryos   2.21 ± 1.10   2.87 ± 1.20 0.0001 No. of embryos transferred   2.83 ± 0.50   2.79 ± 0.40 NS No. of cryopreserved embryos   4.50 ± 3.93   5.77 ± 4.87 NS Clinical pregnancy (%) 46/96 (47.9) 52/94 (55.3) NS Multiple pregnancy (%) 15/46 (32.6) 17/52 (32.7) NS
  • 38.
  • 39.
  • 41.
  • 42. THANK YOU Dr. Hesham Al-Inany MD, PhD e-mail : hesham@khosoba.com

Notas del editor

  1. 06/28/11
  2. 06/28/11
  3. 06/28/11
  4. * *
  5. * *
  6. 06/28/11
  7. IBSA Institut Biochimique SA 28/06/11